ArticleF1000Research2025

OnabotulinumtoxinA blockade of the sphenopalatine ganglion in treatment-resistant chronic migraine (MiBlock): rationale, design and study protocol for a multi-centre, investigator initiated, randomised, quadruple-blinded placebo-controlled trial.

Tore Wergeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.